Musk's xAI to raise up to $12 billion in debt for AI expansion, WSJ reports
Valor Equity Partners, an investment firm whose founder, Antonio Gracias, has close ties to Musk, is in talks with lenders to raise the capital, according to the report.
The money would be used to buy a massive supply of advanced Nvidia chips that would be leased to xAI for a new huge data center meant to help train and power its AI chatbot Grok, the WSJ reported.
Advertisement
Valor and xAI did not immediately respond to Reuters' requests for comment.
Some lenders want the debt to be repaid within three years and to cap the amount of money borrowed in order to limit their risk, the report said.
Training and deploying advanced AI systems is expensive, requiring costly hardware, intensive compute and skilled engineers in a highly competitive market where rivals such as OpenAI, Google and China's DeepSeek are trying to dominate the technology.
XAI is training Grok on 230,000 graphics processing units, including Nvidia's 30,000 GB200 AI chips, in a supercluster, with inference handled by the cloud providers, Musk said in a post on X on Tuesday.
Advertisement
He added that another supercluster will soon launch with an initial batch of 550,000 GB200 and GB300 chips.
The AI startup was expected to burn through about $13 billion over the course of 2025, according to media reports.
Earlier this month, the Financial Times reported that xAI was in talks to raise more money in a deal that could value the AI startup between $170 billion and $200 billion.
In response, Musk had said xAI was not seeking funding. "We have plenty of capital."
(Reporting by Jaspreet Singh in Bengaluru; Editing by Anil D'Silva and Alan Barona)
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
22 minutes ago
- Yahoo
Exclusive-China's Sciwind is in talks to license weight-loss drug in US, CEO says
By Andrew Silver HANGZHOU (Reuters) -China's Sciwind Biosciences is in talks with a U.S. company interested in licensing its experimental weight-loss drug for American patients, the drugmaker's chief executive told Reuters. Overweight patients treated with Sciwind's ecnoglutide drug lost an average of 10% to 15% of their body weight, roughly in line with results from Novo Nordisk's top-selling obesity treatment Wegovy, according to a late-stage study published in medical journal The Lancet Diabetes & Endocrinology in June. 'We also hope we are able to successfully license out, and they will apply for approval in the U.S.,' Sciwind Biosciences CEO Pan Hai said, declining to identify the firm or disclose financial terms under discussion. Reuters is the first to report on the potential U.S. licensing deal. Pan said its potential partner hoped to gain U.S. marketing approval to prescribe ecnoglutide for multiple medical conditions and would carry out further clinical development. The talks are not yet at the stage of discussing a detailed contract, he added. Sciwind is hoping the partner could use clinical data accumulated in China and Australia to accelerate the development. Pan expects it would take at least three years for a U.S. partner to bring Sciwind's drug to market in the United States, and said the FDA might require a bridging study to compare ecnoglutide's pharmacokinetics - how it moves through the body - among different patient populations. Ecnoglutide is administered as a once-weekly injection. It belongs to a class of drugs called GLP-1 receptor agonists, which work by helping control blood sugar levels and triggering a feeling of fullness. Novo's Wegovy and Eli Lilly and Co's Zepbound lead the U.S. market for weight-loss drugs, but their relatively high prices leave room for new competitors to offer cheaper alternatives. Sciwind has applied to sell ecnoglutide in China for weight management and the treatment of type II diabetes. Other approved weight loss medicines in China also include drugs from Novo, Lilly and other drugmakers. Pan said he could not give an estimated time of approval. The company is also in talks to license the drug to partners for other markets, including in Latin America and the Middle East. Pricing in China would be in line with other approved competitors, Pan said, adding the company would not engage in a "price war" there. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
22 minutes ago
- Yahoo
Ukraine says Starlink's global outage hit its military communications
By Max Hunder KYIV (Reuters) -Starlink systems used by Ukrainian military units were down for two and a half hours overnight, a senior commander said, part of a global issue that disrupted the satellite internet provider. Ukraine's forces are heavily reliant on thousands of SpaceX's Starlink terminals for battlefield communications and some drone operations, as they have proved resistant to espionage and signal jamming throughout the three and a half years of fighting Russia's invasion. Starlink experienced one of its biggest international outages on Thursday when an internal software failure knocked tens of thousands of users offline. "Starlink is down across the entire front," Robert Brovdi, the commander of Ukraine's drone forces, wrote on Telegram at 10:41 p.m. (1941 GMT) on Thursday. He updated his post later to say that by about 1:05 a.m. on Friday the issue had been resolved. He said the incident had highlighted the risk of reliance on the systems, and called for communication and connectivity methods to be diversified. "Combat missions were performed without a (video) feed, battlefield reconnaissance was done with strike (drones)," Brovdi wrote. Oleksandr Dmitriev, the founder of OCHI, a Ukrainian system that centralises feeds from thousands of drone crews across the frontline, told Reuters the outage showed that relying on cloud services to command units and relay battlefield drone reconnaissance was a "huge risk". "If connection to the internet is lost ... the ability to conduct combat operations is practically gone," he said, calling for a move towards local communication systems that are not reliant on the internet. Although Starlink does not operate in Russia, Ukrainian officials have said that Moscow's troops are also widely using the systems on the frontlines in Ukraine.
Yahoo
30 minutes ago
- Yahoo
Tesla misses Wall Street expectations on revenue, earnings per share in second quarter earnings
Tesla's second quarter earnings signaled the company continues to go through a difficult patch, with both revenue and adjusted earnings per share missing the average Wall Street estimates. Revenue was $22.5 billion, down approximately 12% year over year, the sharpest decline in at least a decade. Adjusted earnings per share was 40 cents, down from 52 cents a year ago. Analysts, on average, had forecast revenue between $22.62 billion and $22.64 billion and adjusted EPS of $0.41 to $0.42 per share, with Tesla below the midpoint on each. Tesla's double-digit percentage revenue decline was primarily attributed to the ongoing slump in vehicle deliveries. Improved energy storage deployments and new service offerings provided minor offsets, but could not outweigh the hit from lagging car sales and persistent price competition across the electric vehicle industry. Operating income also fell significantly, coming in at $923 million, which was below consensus estimates of $1.23 billion. Net income dropped year over year as margins continued to shrink, pressured by lower average selling prices, higher raw material costs, and global trade headwinds. Tesla had previously reported deliveries of more than 384,000 vehicles in the quarter—a drop of more than 13% from the previous year—with production holding steady at just over 410,000 vehicles. This marks the second quarter in a row of reduced year-over-year deliveries. Wall Street had entered the earnings week with tepid expectations, citing declining sales, compressed margins, and elevated spending on research and development as factors dampening short-term prospects. While Tesla's results were slightly weaker than forecast, shares saw only a modest uptick in after-hours trading, as investors focused on the company's long-term ambitions rather than current sales struggles. Robotaxi, AI, and a new affordable model Tesla's leadership used the earnings release to reaffirm its pivot toward next-generation technologies. CEO Elon Musk highlighted the launch of Tesla's first Robotaxi pilot service in Austin, along with vague remarks related to the ongoing development of a long-rumored 'more affordable' Tesla model. Musk signaled that, amid stiffer automotive competition, Tesla's strategy increasingly centers on breakthroughs in autonomy, artificial intelligence, and energy solutions as pillars for future growth. Multiple challenges continue to weigh on Tesla, including expiring U.S. electric vehicle tax credits in October 2025, ongoing trade disputes and tariffs affecting costs and global supply, and intensifying competition from established automakers and Chinese EV brands. More generally, the brand has growing reputational issues associated with Musk and his support of President Donald Trump, even after the two had a falling out that coincided with fierce criticism of each upon the other. During Musk's brief role helping the administration, his sometimes successful attempts at slashing government spending provoked ire from much of Tesla's traditional customer base, with environmentalist and left-leaning politics. Other investors said they wished the distraction would go away. For this story, Fortune used generative AI to help with an initial draft. An editor verified the accuracy of the information before publishing. This story was originally featured on